These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27546217)

  • 21. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
    Waineo MF; Kuhn TC; Brown DL
    J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetic model of Vancomycin based on therapeutic drug monitoring data in critically ill septic patients.
    Kovacevic T; Miljkovic B; Kovacevic P; Dragic S; Momcicevic D; Avram S; Jovanovic M; Vucicevic K
    J Crit Care; 2020 Feb; 55():116-121. PubMed ID: 31715528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline.
    Marqués-Miñana MR; Saadeddin A; Peris JE
    Br J Clin Pharmacol; 2010 Nov; 70(5):713-20. PubMed ID: 21039765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?
    Udy AA; Covajes C; Taccone FS; Jacobs F; Vincent JL; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2013 Jun; 41(6):564-8. PubMed ID: 23473944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease.
    Zhao W; Zhang D; Fakhoury M; Fahd M; Duquesne F; Storme T; Baruchel A; Jacqz-Aigrain E
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3191-9. PubMed ID: 24663023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation.
    Lim HS; Chong YP; Noh YH; Jung JA; Kim YS
    J Clin Pharm Ther; 2014 Apr; 39(2):196-203. PubMed ID: 24428720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population pharmacokinetics of vancomycin in Chinese infants
.
    Sheng XY; Chen CY; Ma LY; Liu YO; Zhou Y; Cui YM
    Int J Clin Pharmacol Ther; 2017 Jul; 55(7):558-566. PubMed ID: 28406088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of vancomycin loading doses in intermittent infusion regimens.
    Šíma M; Hartinger J; Cikánková T; Slanař O
    J Infect Chemother; 2018 Apr; 24(4):247-250. PubMed ID: 29195829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration.
    Escobar L; Andresen M; Downey P; Gai MN; Regueira T; Bórquez T; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2014 Aug; 44(2):163-7. PubMed ID: 24837847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of a population pharmacokinetics model of vancomycin in 94 infants with septicemia and its application in individualized therapy.
    Li Z; Li H; Wang C; Jiao Z; Xu F; Sun H
    BMC Pharmacol Toxicol; 2021 May; 22(1):26. PubMed ID: 33947475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations.
    Thomson AH; Staatz CE; Tobin CM; Gall M; Lovering AM
    J Antimicrob Chemother; 2009 May; 63(5):1050-7. PubMed ID: 19299472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clearance of vancomycin during continuous infusion in Intensive Care Unit patients: correlation with measured and estimated creatinine clearance and serum cystatin C.
    Kees MG; Hilpert JW; Gnewuch C; Kees F; Voegeler S
    Int J Antimicrob Agents; 2010 Dec; 36(6):545-8. PubMed ID: 20863668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population pharmacokinetic analysis of vancomycin in patients with hematological malignancies.
    Buelga DS; del Mar Fernandez de Gatta M; Herrera EV; Dominguez-Gil A; García MJ
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4934-41. PubMed ID: 16304155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of cerebral fluid drainage on the pharmacokinetics of vancomycin in neurosurgical patients.
    Ichie T; Urano K; Suzuki D; Okada T; Kobayashi N; Hayashi H; Sugiura Y; Yamamura K; Sugiyama T
    Pharmazie; 2015 Jun; 70(6):404-9. PubMed ID: 26189303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.
    Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM
    Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort study.
    Donadello K; Roberts JA; Cristallini S; Beumier M; Shekar K; Jacobs F; Belhaj A; Vincent JL; de Backer D; Taccone FS
    Crit Care; 2014 Nov; 18(6):632. PubMed ID: 25416535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric Patients With Solid or Hematological Tumor Disease: Vancomycin Population Pharmacokinetics and Dosage Optimization.
    Guilhaumou R; Marsot A; Dupouey J; Galambrun C; Boulamery A; Coze C; Simon N; André N
    Ther Drug Monit; 2016 Oct; 38(5):559-66. PubMed ID: 27631462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Actual body weight-based vancomycin dosing in neonates.
    Pokorná P; Šíma M; Černá O; Allegaert K; Tibboel D; Slanař O
    J Chemother; 2019 Oct; 31(6):307-312. PubMed ID: 30983533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased vancomycin clearance in patients with congestive heart failure.
    Shimamoto Y; Fukuda T; Tominari S; Fukumoto K; Ueno K; Dong M; Tanaka K; Shirasaka T; Komori K
    Eur J Clin Pharmacol; 2013 Mar; 69(3):449-57. PubMed ID: 22791272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.